InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by GANNON STEVEN, Director. Officer active across 1 companies, notably Fusion Pharmaceuticals Inc.. In total, 6 disclosures have been recorded. Total volume traded: €123k. The latest transaction was disclosed on 23 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€19,2342,829 shares@ €6.798931.2% of flow
Common Stock
SEC:0001209191-21-053000·
Ideal exit: 20 May 2022 (T+270)
€19,2342,829 shares@ €6.798915.6% of flow
Common Stock
SEC:0001209191-21-053000:0·
Ideal exit: 20 May 2022 (T+270)
€1,176171 shares@ €6.87841.9% of flow
Common Stock
SEC:0000899243-21-033814·
Ideal exit: 15 May 2022 (T+270)
€1,176171 shares@ €6.87841.0% of flow
Common Stock
SEC:0000899243-21-033814:0·
Ideal exit: 15 May 2022 (T+270)
€41,2576,000 shares@ €6.876166.9% of flow
Common Stock
SEC:0000899243-21-033258·
Ideal exit: 13 May 2022 (T+270)
€41,2576,000 shares@ €6.876133.5% of flow
Common Stock
SEC:0000899243-21-033258:0·
Ideal exit: 13 May 2022 (T+270)
6 of 6 declarations
About GANNON STEVEN
Steven Gannon is a Board Member of Fusion Pharmaceuticals Inc. He contributes to the governance and strategy of the company. Steven brings valuable expertise in the pharmaceutical sector.
